6:21 PM
 | 
May 27, 2009
 |  BC Extra  |  Company News

Angiotech up after Taxus approval

Angiotech Pharmaceuticals Inc. (TSX:ANP; NASDAQ:ANPI) gained C$0.57 (43%) to C$1.89 on Wednesday after FDA approved...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >